Pfizer-BioNTech's COVID Vaccine Gets Approval in South Korea for Kids 5-11 - Reuters

Seeking Alpha2022-02-23

South Korea approved Pfizer (NYSE:PFE) BioNTech's (NASDAQ:BNTX) coronavirus vaccine for use in children ages five to 11 years, Reuters reported citing the Asian country's food and drug ministry.The ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • tobe.....
    2022-02-23
    tobe.....
    Big player alway knowing their ways and get supported[LOL] 
Leave a comment
1